Just after 9 a.m. on Friday, Feb. 6, 2026, final beams of oxygen ions—oxygen atoms stripped of their electrons—circulated ...

Iambic’s physics-informed NeuralPLexer is intended to enhance protein–ligand modeling, enabling broader exploration of ...

A major upgrade to the LHCb experiment at CERN is under threat after the UK cancelled its contribution towards it. The decision by the Science and Technology Facilities Council (STFC) to defund the ...

Meditation doesn’t "empty the mind", as some imagine. In fact, brain scans reveal that the meditating mind is not in a ...

Professor of Experimental Physics Edward Laird is part of an international team awarded major funding of £1.5 million to develop quantum computers in ...

For those willing to put in the effort, Japan offers strong research environments, lasting professional networks and a distinctive academic culture that shapes careers long after researchers leave, sa ...

Multi-year partnership will utilize Iambic’s broad suite of AI drug discovery technologies and wet lab capabilities to advance collaboration programs initially in Takeda’s Oncology and ...

Fusion has been in the news a lot recently given its promise as an abundant and clean source of energy that could help power ...

Iambic Therapeutics, a San Diego–based start-up that harnesses physics and artificial intelligence for drug discovery, is ...

Chemistry serves as the foundational pillar of material innovation and transformation. It supports and shapes almost every aspect of modern industries. Recently, XtalPi Inc. (2228.HK), a global leader ...

In a low-slung Maryland lab, scientists are racing to build a machine that could help turn cancer into a manageable disease while simultaneously threatening the cryptography that shields everything ...